The Africa Centers for Disease Control and Prevention (Africa CDC) and the Coalition for Epidemic Preparedness Innovations (Cepi) have announced an ambitious goal: to locally produce 60% of the vaccines needed by the continent by 2040.
This is learned from a note released on the sidelines of the work of the Forum on the supply chain for vaccine production in Africa, held in Kenya, during which the main actors involved “explored sustainable ways to provide essential input materials for production of vaccines,” at a time when the continent is witnessing a surge in production capacity.
Demand for vaccines in Africa is expected to increase from around 1.4 billion doses to over 2.1 billion by 2040. The Africa CDC has identified several barriers that require urgent interventions to support local vaccine manufacturers in establishing supply chains. strong and stable supplies, thus enabling the African industry to develop, produce and supply approximately 60% of the vaccine doses needed by 2040.
The initiative aims to develop a reliable and robust vaccine manufacturing ecosystem across the continent by localizing the supply of critical input materials and harmonizing trade regulations. Susan Nakhumicha, Cabinet Secretary, Ministry of Health of the Republic of Kenya, highlighted the importance of developing the pharmaceutical sector as a key part of building a progressive and sustainable healthcare system in Kenya. [Da Redazione InfoAfrica]
© All rights reserved
Read our focus on the necessary development of the healthcare supply chain on the continent: